Addressing Key Challenges in Drug Safety (Strategic Focus)
Price:
$3 395.00
Introduction
High profile drug withdrawals and negative public attention has placed drug safety at the top of the pharmaceutical industry’s agenda. This report will examine pharmacovigilance technology solutions designed to alleviate the challenges in drug safety management faced by the pharmaceutical industry and the regulatory agencies.
Scope
Identifies the key forces driving the adoption of pharmacovigilance technology solutions
Analyzes the crucial issues that will impede the uptake of drug safety monitoring tools
Discusses the key functionalities needed for a complete pharmacovigilance solution
Offers insight into how IT vendors can improve their products
Highlights
Pharma companies must adapt to constantly changing government regulations to ensure compliance and eventual approval of their drug products, and response to these new rules is driving the adoption of pharmacovigilance solutions. It is essential for pharma companies to implement proactive pharmacovigilance strategies which encompass strong data management systems, signal detection technologies, and adverse event reporting systems to ensure production of a safe and effective drug that will be approved and will maintain a favorable risk-benefit ratio post-approval. The industry is still skeptical of the benefits provided by signal detection technologies. IT vendors must take an active role in educating companies about these technologies, and position signal detection as an essential tool for developing comprehensive risk management strategies which will not only benefit the company, but ultimately the public.
Reasons to Purchase
Validate your market messaging and positioning in the pharmaceutical industry
Identify strategies that will increase adoption of pharmacovigilance technologies
Understand the technology trends that are shaping the future of drug safety.